Neuro Immunoassay Market Analysis

Neuro Immunoassay Market: Global Industry Analysis 2012 – 2016 and Opportunity Assessment; 2017 – 2027

Neuro Immunoassay Market: Global Industry Analysis 2012 – 2016 and Opportunity Assessment; 2017 – 2027
  • SELECT LICENSE TYPE :

  • US$5,000
  • US$7,500
  • US$10,000

This Neuro Immunoassay market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Neuro Immunoassay market.


Immunoassay is a bioanalytical method in which a quantitative analysis depends on the interaction of antigen and antibody. Neuro Immunoassay is a technique that is a quick and accurate test that can be used in laboratory and on-site to detect specific molecules. Immunoassays are the procedure that rely on the procedure of an antibody to bind to a specific structure of a molecule. Antibodies in this are proteins that are generated by animals in response to the invasion of the antigen produced. It function on the antigen-antibody interaction procedure. Antibodies are found in blood and tissue fluids and will bind to the antigens whenever is encountered. Antibodies are highly specific, only act on its specific antigens. If these antibodies are purified from the blood, monoclonal and polyclonal antibodies are ideal for the reagents to detect and monitor certain specific target molecules from other substances. Neuro Immunoassay have been widely used for the pharmaceutical analysis such as diagnosis of disease, drug monitoring, pharmacokinetic and bioequivalence study of drug discovery. Immunoassay are of different format such as competitive inhibition assay, monoclonal-polyclonal sandwich assays, rapid assays and antigen-down immunoassays. The importance of neuro immunoassay in pharmaceutical industry is due to its inherent specificity, high- throughput and sensitivity for the analysis of biological samples.

Neuro Immunoassay Market: Drivers and Restraints

Market Growth Analysis

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Neuro Immunoassay Market:
Global Industry Analysis 2012 – 2016 and Opportunity Assessment; 2017 – 2027
v>

Neuro Immunoassay market is growing with the increasing prevalence cases of neurodegenerative diseases. The growing investments on neurobiology is expected to drive the market. The increasing geriatric population, growing technological advancement is expected to act as a driver to the global neuro immunoassay market. Increasing awareness about application of immunoassay in diagnosis and monitoring purpose of Neuro diseases. The stringent regulations by government, high cost associated with the procedure and lack of experience in using these tchniques are expected to act as a restraint to the market

Neuro Immunoassay Market: Segmentation

The global Neuro Immunoassay market is classified on the basis of product type, technology, application and end users

Neuro Immunoassay Market: Overview

Neuro Immunoassay Market: Regional Overview

Market: Key Players

Some of the players in Neuro Immunoassay market includes: Intrinsic LifeSciences, Danaher Corporation (Beckman Coulter), Becton Dickinson and Company, Akers Biosciences, Inc., Abbott Laboratories, Inc, EDP Biotech Corporation, Hologic (Gen-Probe), Biomérieux and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and applications.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.

Competitive Positioning Matrix

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.



Average Selling Price (ASP) Analysis

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Global Neuro Immunoassay market, by Technology

  • Radioimmunoassays (RIA)
  • Polymerase Chain Reaction (PCR)
  • ELISA
  • Western Blot
  • Rapid Tests
  • ELISPOT

Global Neuro Immunoassay market, by Product Type

  • Reagents and Kits
  • Analysers

Global Neuro Immunoassay market, by Application

  • Alzheimer’s Disease
  • Parkinson’s Disease
  • Huntington’s Disease
  • ALS
  • Spinal Muscular Atrophy (SMA)

Global Neuro Immunoassay market, by Product Type

  • Hospitals
  • Clinics
  • Academic Organizations
  • Biopharmaceutical Companies
  • Pharmaceutical Companies
  • Others

Based on Technology is the major segment of the market that includes Radioimmunoassays (RIA),  Polymerase Chain Reaction (PCR), ELISA, Western Blot, Rapid Tests and ELISPOT. Based on product type Reagents and Kits and Analysers. The other segment includes end users that includes hospitals, clinics, academic organizations, biopharmaceutical companies, pharmaceutical companies and others. The increasing government initiatives for the diagnosis and treatment of neuro disorders is expected to act as the driverto the overall Neuro Immunoassay market.

Neuro Immunoassay Market: Regional Overview

Region wise, the global Neuro Immunoassay market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is expected to lead the market due to better economic condition, better government initiatives and more business investments for research and development. Latin America market is expected to hold second largest market share followed by Europe due to increasing trend towards racing competitions and awareness among population.

Market: Key Players

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

The regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia-Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • The Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.
Get in touch

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Business Development

* indicates mandatory fields
Our Clients

Request Sample Request customization Request Methodology